Genaissance Pharmaceuticals Inc. announced it has identified genetic markers useful in identifying which people will respond best to cholesterol-lowering drugs. A study of 500 patients taking Lipitor, Pravachol, and Zochor compared their response to drugs over 16 weeks with a genetic profile that analyzed 100 genes. Among other things, the company says it may use […]
“April 1, 2002 Intelligence: Late Breaking Lab News”
- By Robert Michel
- > From the Volume IX No. 5 - April 1, 2002 Issue
